Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
Go back to Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients| ORAGENICS (NYSE: OGEN) | Delayed: 0.55 -0.01 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.56 | 52 Week High | $2.12 | |||
| Open | $0.56 | 52 Week Low | $0.33 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.54 | EPS | $-0.45 | |||
| Volume | 29,953 | |||||
